Hopman Mark sold BBNX
December 2, 2025 · Form 4 insider transaction
Hopman Mark sold 856 shares of Beta Bionics, Inc. at $29.34 per share, a transaction worth $25.1K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 104 days after the transaction.
Direction
Disposed (sell-side)
Shares
856
Price
$29.34
Total value
$25.1K
InsiderHopman Mark
RoleOfficer
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 2, 2025
Filing dateMarch 16, 2026
Shares owned after138,277
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.